雄激素受体:不同乳腺癌亚型中的结构,信号,功能和潜在的药物发现生物标志物
Nirali Shukla1, Kanisha Shah2, Deepshikha Rathore1
1Institute of Science, Nirma University, Ahmedabad, Gujarat 382481, India.
Life sciences
|May 6, 2024
概括
雄激素受体 (AR) 是乳腺癌 (BC) 发病的一个关键因素. 向AR为AR阳性BC提供了一个有希望的治疗策略,目前正在进行的研究正在探索其在各种BC亚型中的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 雄激素受体 (AR) 在乳腺癌 (BC) 的发展和进展中起着重要作用.
- 在超过70%的原发性和转移性乳腺瘤中观察到AR表达,这表明其作为生物标志物和治疗点的潜力.
- AR信号与涉及BC病原和临床治疗策略的关键途径相互作用.
研究的目的:
- 审查AR在不同乳腺癌分子亚型中的瘤发生和攻击性中的多方面的作用.
- 讨论AR作为AR阳性乳腺癌的治疗点的潜力.
- 探索正在进行的研究和临床策略,以在乳腺癌治疗和预防中针对AR.
主要方法:
- 对研究AR表达,信号通路和乳腺癌治疗向的研究进行文献综述.
- 对AR在各种乳腺癌分子亚型中的作用的分析.
- 对乳腺癌AR向治疗的初步临床数据和正在进行的试验的审查.
主要成果:
- 甲状腺癌涉及促进特定乳腺癌亚型的瘤发生和攻击性.
- 已批准用于前列腺癌的AR向药物,在AR阳性乳腺癌的初步研究中显示出有前途.
- 对AR阳性的预后和预测价值需要进一步阐明患者分层.
结论:
- AR是乳腺癌的关键因素,具有潜在的治疗点,特别是在AR阳性亚型中.
- 针对AR,作为单一疗法或组合疗法,是一种不断发展的战略,具有有希望的初步结果.
- 需要进一步的研究来优化AR向疗法,并确定受益最多的患者群体.
相关概念视频
01:26Signal Transduction: Overview
8.5K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
8.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:31Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
01:15G Protein-coupled Receptors
11.8K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.8K
01:26Receptor Tyrosine Kinases
12.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.8K
01:28Structure-Activity Relationships and Drug Design
701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701